Navigation Links
Is Duloxetine more or less effective than Fluoxetine in children and teens with MDD?
Date:5/19/2014

New Rochelle, NY, May 19, 2014Two studies of the anti-depressive drug duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI), compared its effectiveness and safety to either fluoxetine or placebo in children and adolescents with major depressive disorder (MDD). The results of these first controlled trials of duloxetine in pediatric patients with MDD are published in Journal of Child and Adolescent Psychopharmacology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The articles are available free on the Journal of Child and Adolescent Psychopharmacology

.

Graham Emslie, MD and coauthors evaluated the efficacy and safety of a fixed dose of duloxetineeither 60 mg or 30 mg once a dayversus 20 mg daily of fluoxetine or placebo in children ages 7-11 years and adolescents ages 12-17 years. In the article "A Double-Blind Efficacy and Safety Study of Duloxetine Fixed Doses in Children and Adolescents with Major Depressive Disorder" they compare the treatments based on worsening of suicidal ideation, emergence of suicidal behavior, and adverse effects including abnormal findings on an electrocardiogram and laboratory tests.

Sarah Atkinson, MD and colleagues compared a flexible dosing regimen of duloxetine (60-120 mg daily) to fluoxetine (20-40 mg daily) or placebo and reported measures from a depression rating scale and a suicide severity rating scale, as well as treatment-related adverse events, in the article "A Double-Blind Efficacy and Safety Study of Duloxetine Flexible Dosing in Children and Adolescents with Major Depressive Disorder".

Neither study found a significant difference in response between the two drugs and placebo. The authors suggest that this may be due to the complexity of these novel studies and offer observations that may direct the design of future investigations.

"Drs. Emslie and Atkinson and their colleagues took a fascinating approach towards testing the efficacy of a novel SNRI in the pediatric population," said Harold S. Koplewicz, MD, Editor-in-Chief of Journal of Child and Adolescent Psychopharmacology, and President, Child Mind Institute, New York, NY. "Researchers are of course excited by positive results, but in this case the curious lack of response tells us volumes about how to better design complex studiesstudies that may soon give us uncommon insight into our pharmacologic interventions."


'/>"/>
Contact: Kathryn Ruehle
kruehle@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related medicine news :

1. Medication duloxetine helps reduce pain from chemotherapy
2. Widely used drug no more effective than FDA approved medication in treating epileptic seizures
3. New agent may enhance effectiveness of radiotherapy
4. A form of immune therapy might be effective for multiple myeloma
5. Universal neuromuscular training an inexpensive, effective way to reduce
6. Study finds family-based exposure therapy effective treatment for young children with OCD
7. New study says probiotic use for infant colic is not effective in reducing symptoms
8. New human trial shows stem cells are effective for failing hearts
9. Heparin more effective than bivalirudin in patients during emergency heart procedure
10. Researchers: Biomarkers predict effectiveness of radiation treatments for cancer
11. Primary androgen deprivation therapy ineffective for most men with early prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Is Duloxetine more or less effective than Fluoxetine in children and teens with MDD?
(Date:5/24/2016)... ... May 24, 2016 , ... A newly released report reveals that ... access to trusted resources, both in face-to-face interactions and online. In “Heard, Not Judged ... concluded that the creative use of mobile digital devices can be an effective tool ...
(Date:5/24/2016)... ... May 24, 2016 , ... The Radiosurgery Society (RSS), ... radiosurgery, is recognizing five medical residents and students for their outstanding contributions to ... The awards will be presented at the 2016 SRS/SBRT Scientific Meeting taking place ...
(Date:5/24/2016)... ... May 24, 2016 , ... Tuesday, May 24, Women's Excellence in Wellness, ... with Young Living Essential Oils, taught by Patti Dolan, RYT, a Young Living ... Yoga Flow is 6:30pm - 7:15pm followed by a small intro to the Oils ...
(Date:5/24/2016)... ... , ... WaterAid launched the #perioddrama campaign to mark Menstrual Hygiene Day on May ... the world who do not have access to a toilet, even when they’re on their ... of #perioddrama. The (sometimes hilarious) results help shine a light on the awkwardness that women ...
(Date:5/24/2016)... ... May 24, 2016 , ... Local chiropractor ... on September 21, 2016. Dr. Gerard, who holds a Doctorate of Chiropractic and ... organization promoting health and wellness in Third World countries where resources are limited. ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... WASHINGTON , May 23, 2016 The World ... PrePex device to include adolescents aged 13 years, ... MedTech, can be offered for adult and adolescent males in ... Africa . PrePex was the first male circumcision device ... Circ MedTech,s CEO, Eddy Horowitz said: " The ...
(Date:5/23/2016)... 23, 2016   Purdue Pharma L.P.  today ... agreement with Egalet Corporation and Acura Pharmaceuticals, Inc. ... of the agreement the companies will exchange valuable ... three companies to develop and sell several opioid ... agreement reflects the commitment of Purdue Pharma to ...
(Date:5/20/2016)... 20, 2016 According to the 2016 ... increasing demand for affordable healthcare solutions as since the early ... rise. In countries like the US, the healthcare cost rose ... the consumer price index inflation rate stood at an average ... up to 3.62% during the same time period. This can ...
Breaking Medicine Technology: